July 1, 2026 · Form 4 insider transaction
Iijima Masami bought 1,800 shares of Takeda Pharmaceutical Company Limited at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest on June 1, 2029.